Citadel Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-47,146
| Closed | -$5.06M | – | 6783 |
|
|
2023
Q1 | $5.06M | Sell |
47,146
-11,190
| -19% | -$1.2M | ﹤0.01% | 1815 |
|
|
2022
Q4 | $6.42M | Buy |
+58,336
| New | +$6.42M | ﹤0.01% | 1600 |
|
|
2022
Q3 | – | Sell |
-647,703
| Closed | -$18.3M | – | 7036 |
|
|
2022
Q2 | $18.3M | Buy |
647,703
+634,006
| +4,629% | +$17.9M | ﹤0.01% | 875 |
|
|
2022
Q1 | $518K | Buy |
+13,697
| New | +$518K | ﹤0.01% | 4406 |
|
|
2021
Q3 | – | Sell |
-38,438
| Closed | -$944K | – | 7357 |
|
|
2021
Q2 | $944K | Sell |
38,438
-17,700
| -32% | -$435K | ﹤0.01% | 4081 |
|
|
2021
Q1 | $1.03M | Buy |
+56,138
| New | +$1.03M | ﹤0.01% | 3906 |
|